CS logo
small CS logo
Tilda Research

Irvine, California, United States
Research institute in Redlands, California
1815 W Redlands Blvd, Redlands, CA 92373

About Tilda Research


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Tilda Research


During the past decade, Tilda Research conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
GEM05 for Patients With Multiple Myeloma More Than 65 Years Old
2005-03-01
2009-12-01
Completed
260
GEM05 for Patients With Multiple Myeloma Under 65 Years
2006-03-01
2008-12-01
Completed
390
Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO)
2007-07-01
2014-10-01
Completed
60
PUVA Versus PUVA + IFN Alpha 2a in Mycosis Fungoides
2000-01-01
Terminated
54
Phase II Study of SBRT as Treatment for Oligometastases in Prostate Cancer
2014-08-01
2021-07-01
Completed
68
Computerized Registry of Patients With Venous Thromboembolism (RIETE)
2001-03-01
2027-12-01
Recruiting
120,000
Validation of the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Prognostic Classification for Targeted Therapies (TKI/mTOR Inhibitors) in Second Line After First Line Treatment With Pazopanib
2016-12-20
2017-04-17
Completed
530
A Tube Feeding Study in Malnourished Population With Diabetes
2018-11-29
2020-07-01
Completed
49

Rows per page:

1–16 of 16

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Tilda Research" #1 collaborator was "National Institute on Aging (NIA)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Tilda Research


According to Clinical.Site data, the most researched conditions in "Tilda Research" are "Alzheimer Disease" (2 trials), "Articular Cartilage Defect" (1 trials), "Articular Cartilage Degeneration" (1 trials), "Early Alzheimer's Disease" (1 trials) and "Urinary Tract Infections" (1 trials). Many other conditions were trialed in "Tilda Research" in a lesser frequency.

Clinical Trials Intervention Types at Tilda Research


Most popular intervention types in "Tilda Research" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Donanemab" (2 trials), "Autologous Chondrocyte Implantation (CartiLife®)" (1 trials), "Experimental: ALZ-801" (1 trials) and "LBP-EC01" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Tilda Research


The vast majority of trials in "Tilda Research" are 5 trials for "All" genders.

Clinical Trials Status at Tilda Research


Currently, there are NaN active trials in "Tilda Research". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Tilda Research, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Tilda Research, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status